BR9908391A - Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina - Google Patents
Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecinaInfo
- Publication number
- BR9908391A BR9908391A BR9908391-4A BR9908391A BR9908391A BR 9908391 A BR9908391 A BR 9908391A BR 9908391 A BR9908391 A BR 9908391A BR 9908391 A BR9908391 A BR 9908391A
- Authority
- BR
- Brazil
- Prior art keywords
- derivative
- synergistically
- combination
- composition containing
- tumor composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
São apresentados o uso combinado de 4-demetoxi-3'-deamino-3'-aziridinil-4'-metanosulfonil daunorubicina ou 4-demetoxi-N,N-bis(2-cloroetil)-4'-metanosulfonil daunorubicina e um inibidor de topoisomerase I antineoplástico no tratamento de tumores e o uso de 4-demetoxi-3'deamino-3'-aziridinil-4'-metanosulfonil daunorubicina no tratamento de tumores cerebrais.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9806324.1A GB9806324D0 (en) | 1998-03-24 | 1998-03-24 | Antitumour synergetic composition |
PCT/EP1999/001897 WO1999048503A1 (en) | 1998-03-24 | 1999-03-19 | Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9908391A true BR9908391A (pt) | 2000-10-31 |
Family
ID=10829188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9908391-4A BR9908391A (pt) | 1998-03-24 | 1999-03-19 | Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina |
Country Status (29)
Country | Link |
---|---|
US (1) | US6403563B1 (pt) |
EP (1) | EP1067941B1 (pt) |
JP (1) | JP2002507571A (pt) |
KR (1) | KR20010034619A (pt) |
CN (2) | CN1150002C (pt) |
AR (1) | AR018166A1 (pt) |
AT (1) | ATE271388T1 (pt) |
AU (1) | AU758191B2 (pt) |
BR (1) | BR9908391A (pt) |
CA (1) | CA2324610A1 (pt) |
CZ (1) | CZ295368B6 (pt) |
DE (1) | DE69918819T2 (pt) |
DK (1) | DK1067941T3 (pt) |
EA (1) | EA003134B1 (pt) |
ES (1) | ES2226366T3 (pt) |
GB (1) | GB9806324D0 (pt) |
HU (1) | HUP0101615A3 (pt) |
ID (1) | ID26091A (pt) |
IL (1) | IL138035A0 (pt) |
MY (1) | MY133016A (pt) |
NO (1) | NO20004703D0 (pt) |
NZ (1) | NZ507570A (pt) |
PL (1) | PL343098A1 (pt) |
PT (1) | PT1067941E (pt) |
SI (1) | SI1067941T1 (pt) |
TW (1) | TW576740B (pt) |
UA (1) | UA63000C2 (pt) |
WO (1) | WO1999048503A1 (pt) |
ZA (1) | ZA992255B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6820065B1 (en) * | 1998-03-18 | 2004-11-16 | Ascom Hasler Mailing Systems Inc. | System and method for management of postage meter licenses |
GB9904387D0 (en) * | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
GB9909925D0 (en) * | 1999-04-29 | 1999-06-30 | Pharmacia & Upjohn Spa | Combined preparations comprising anthracycline derivatives |
GB9916882D0 (en) * | 1999-07-19 | 1999-09-22 | Pharmacia & Upjohn Spa | Antitumor synergistic composition |
GB9926843D0 (en) * | 1999-11-12 | 2000-01-12 | Pharmacia & Upjohn Spa | Lipid complex of alkycyclines |
US6627614B1 (en) * | 2002-06-05 | 2003-09-30 | Super Gen, Inc. | Sequential therapy comprising a 20(S)-camptothecin and an anthracycline |
EP1985286A1 (en) * | 2007-04-24 | 2008-10-29 | Biocompatibles UK Limited | Microspheres for treatment of brain tumours |
US8349764B2 (en) | 2007-10-31 | 2013-01-08 | Molycorp Minerals, Llc | Composition for treating a fluid |
US20090107925A1 (en) * | 2007-10-31 | 2009-04-30 | Chevron U.S.A. Inc. | Apparatus and process for treating an aqueous solution containing biological contaminants |
US20110207760A1 (en) * | 2010-02-23 | 2011-08-25 | Valery Alakhov | Sn-38 compositions |
EP3327148B1 (en) | 2010-06-18 | 2021-03-17 | Myriad Genetics, Inc. | Methods of predicting the status of brca1 and brca2 genes in a cancer cell |
DK3109325T3 (en) | 2010-08-24 | 2019-01-28 | Dana Farber Cancer Inst Inc | Methods for predicting anticancer response |
US9233863B2 (en) | 2011-04-13 | 2016-01-12 | Molycorp Minerals, Llc | Rare earth removal of hydrated and hydroxyl species |
CA2839210A1 (en) | 2011-06-17 | 2012-12-20 | Myriad Genetics, Inc. | Methods and materials for assessing allelic imbalance |
BR112014015152A2 (pt) | 2011-12-21 | 2017-07-04 | Myriad Genetics Inc | métodos e materiais para a avaliação da perda de heterozigosidade |
CA3080441A1 (en) | 2012-02-23 | 2013-09-06 | The Children's Hospital Corporation | Methods for predicting anti-cancer response |
US11091808B2 (en) | 2012-06-07 | 2021-08-17 | Institut Curie | Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors |
US10308986B2 (en) | 2013-03-14 | 2019-06-04 | Children's Medical Center Corporation | Cancer diagnosis, treatment selection and treatment |
EP2981624B1 (en) | 2013-04-05 | 2019-12-18 | Myriad Genetics, Inc. | Methods for assessing homologous recombination deficiency and predicting response to cancer treatment |
EP3080292B1 (en) | 2013-12-09 | 2022-02-02 | Institut Curie | Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors |
JP6495316B2 (ja) | 2014-03-07 | 2019-04-03 | セキュア ナチュラル リソーシズ エルエルシーSecure Natural Resources Llc | 極めて優れたヒ素除去特性を備える酸化セリウム(iv) |
AU2015301390B2 (en) | 2014-08-15 | 2021-08-26 | Myriad Genetics, Inc. | Methods and materials for assessing homologous recombination deficiency |
EP4141127A1 (en) | 2021-08-30 | 2023-03-01 | Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln | Method for assessing homologous recombination deficiency in ovarian cancer cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9114549D0 (en) * | 1991-07-05 | 1991-08-21 | Erba Carlo Spa | Mono and bis alkylamino-anthracyclines |
GB9325417D0 (en) * | 1993-12-13 | 1994-02-16 | Erba Carlo Spa | 3'- aziridino-anthracycline derivatives |
-
1998
- 1998-03-24 GB GBGB9806324.1A patent/GB9806324D0/en not_active Ceased
-
1999
- 1999-02-25 TW TW088102834A patent/TW576740B/zh not_active IP Right Cessation
- 1999-03-19 EP EP99914528A patent/EP1067941B1/en not_active Expired - Lifetime
- 1999-03-19 ID IDW20001882A patent/ID26091A/id unknown
- 1999-03-19 IL IL13803599A patent/IL138035A0/xx unknown
- 1999-03-19 CA CA002324610A patent/CA2324610A1/en not_active Abandoned
- 1999-03-19 UA UA2000105982A patent/UA63000C2/uk unknown
- 1999-03-19 EA EA200000978A patent/EA003134B1/ru not_active IP Right Cessation
- 1999-03-19 JP JP2000537551A patent/JP2002507571A/ja not_active Withdrawn
- 1999-03-19 DE DE69918819T patent/DE69918819T2/de not_active Expired - Fee Related
- 1999-03-19 PT PT99914528T patent/PT1067941E/pt unknown
- 1999-03-19 BR BR9908391-4A patent/BR9908391A/pt not_active IP Right Cessation
- 1999-03-19 HU HU0101615A patent/HUP0101615A3/hu unknown
- 1999-03-19 CZ CZ20003493A patent/CZ295368B6/cs not_active IP Right Cessation
- 1999-03-19 AU AU33314/99A patent/AU758191B2/en not_active Ceased
- 1999-03-19 KR KR1020007010503A patent/KR20010034619A/ko not_active Application Discontinuation
- 1999-03-19 WO PCT/EP1999/001897 patent/WO1999048503A1/en not_active Application Discontinuation
- 1999-03-19 AT AT99914528T patent/ATE271388T1/de not_active IP Right Cessation
- 1999-03-19 PL PL99343098A patent/PL343098A1/xx unknown
- 1999-03-19 ES ES99914528T patent/ES2226366T3/es not_active Expired - Lifetime
- 1999-03-19 CN CNB998043141A patent/CN1150002C/zh not_active Expired - Fee Related
- 1999-03-19 US US09/646,096 patent/US6403563B1/en not_active Expired - Fee Related
- 1999-03-19 NZ NZ507570A patent/NZ507570A/xx unknown
- 1999-03-19 CN CNA2004100317041A patent/CN1528334A/zh active Pending
- 1999-03-19 SI SI9930675T patent/SI1067941T1/xx unknown
- 1999-03-19 DK DK99914528T patent/DK1067941T3/da active
- 1999-03-22 MY MYPI99001071A patent/MY133016A/en unknown
- 1999-03-22 AR ARP990101246A patent/AR018166A1/es unknown
- 1999-03-23 ZA ZA9902255A patent/ZA992255B/xx unknown
-
2000
- 2000-09-20 NO NO20004703A patent/NO20004703D0/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9908391A (pt) | Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina | |
BR0008453A (pt) | Composição sinergìstica anti-tumoral | |
IL101145A0 (en) | Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives | |
TR200002355T2 (tr) | 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri | |
BR0207378A (pt) | Tratamento de câncer | |
MY109310A (en) | Antimicrobial method and formulation employing type ii endoglucosidase and antimicrobial agent | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
EP1314431A3 (en) | Newcastle disease virus for therapeutic use | |
MY119042A (en) | Dolastatin derivatives, their preparation and use | |
PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
TR200100054T2 (tr) | Paroksetin metansülfonat | |
NZ507350A (en) | Semi-synthetic ecteinascidins and use in treatment of tumors | |
AU6272598A (en) | Highly lipophilic camptothecin derivatives | |
ES2134801T3 (es) | Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso. | |
CA2401191A1 (en) | A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer | |
SE9802937D0 (sv) | Novel compounds | |
PT1085884E (pt) | Combinacao de compostos seleniferos com gemcitabina ou mitomicina c | |
ATE388960T1 (de) | Glykopeptidderivate mit carboxysacchariden | |
ZA986720B (en) | Photoresponsive sunscreen compositions | |
PA8486601A1 (es) | Formulaciones antiparasitos | |
BR0008454A (pt) | Composição sinergìstica anti-tumoral | |
ES2196769T3 (es) | Uso topico de loperamide para el tratamiento de infecciones microbianas. | |
PT1200099E (pt) | Composicao sinergetica compreendendo derivados de daunorubicina e compostos antimetabolito | |
EA200000025A1 (ru) | 13-дигидро-3'-азиридиноантрациклины | |
BR0009473A (pt) | Tratamento de extravasamento acidental deantraciclinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1928 DE 18/12/2007. |